Reply to Letter to the Editor

Affiliations

Comment

Jerry R Mendell. Mol Ther. 2017.

. 2017 Oct 4;25(10):2238-2240.

doi: 10.1016/j.ymthe.2017.09.003. Epub 2017 Sep 8.

¹ Nationwide Children's Hospital, Research Institute, Columbus, OH 43205, USA. Electronic address: jerry.mendell@nationwidechildrens.org.

No abstract available

Comment on

Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes.
Mendell JR, Sahenk Z, Al-Zaidy S, Rodino-Klapac LR, Lowes LP, Alfano LN, Berry K, Miller N, Yalvac M, Dvorchik I, Moore-Clingenpeel M, Flanigan KM, Church K, Shontz K, Curry C, Lewis S, McColly M, Hogan MJ, Kaspar BK. Mendell JR, et al. Mol Ther. 2017 Apr 5;25(4):870-879. doi: 10.1016/j.ymthe.2017.02.015. Epub 2017 Mar 6. Mol Ther. 2017. PMID: 28279643 Free PMC article.
Unfounded Claims of Improved Functional Outcomes Attributed to Follistatin Gene Therapy in Inclusion Body Myositis.
Greenberg SA. Greenberg SA. Mol Ther. 2017 Oct 4;25(10):2235-2237. doi: 10.1016/j.ymthe.2017.09.002. Epub 2017 Sep 8. Mol Ther. 2017. PMID: 28927986 Free PMC article. No abstract available.

1. Mendell J.R., Sahenk Z., Al-Zaidy S., Rodino-Klapac L.R., Lowes L.P., Alfano L.N., Berry K., Miller N., Yalvac M., Dvorchik I. Follistatin gene therapy for sporadic inclusion body myositis improves functional outcomes. Mol. Ther. 2017;25:870–879. - PMC - PubMed
1. Haidet A.M., Rizo L., Handy C., Umapathi P., Eagle A., Shilling C., Boue D., Martin P.T., Sahenk Z., Mendell J.R., Kaspar B.K. Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors. Proc. Natl. Acad. Sci. USA. 2008;105:4318–4322. - PMC - PubMed
1. Kota J., Handy C.R., Haidet A.M., Montgomery C.L., Eagle A., Rodino-Klapac L.R., Tucker D., Shilling C.J., Therlfall W.R., Walker C.M. Follistatin gene delivery enhances muscle growth and strength in nonhuman primates. Sci. Transl. Med. 2009;1:6ra15. - PMC - PubMed
1. Lin S.Y., Morrison J.R., Phillips D.J., de Kretser D.M. Regulation of ovarian function by the TGF-beta superfamily and follistatin. Reproduction. 2003;126:133–148. - PubMed
1. Sugino K., Kurosawa N., Nakamura T., Takio K., Shimasaki S., Ling N., Titani K., Sugino H. Molecular heterogeneity of follistatin, an activin-binding protein. Higher affinity of the carboxyl-terminal truncated forms for heparan sulfate proteoglycans on the ovarian granulosa cell. J. Biol. Chem. 1993;268:15579–15587. - PubMed